Navidea biopharmaceuticals, inc. rejects unsolicited offer to acquire certain assets

Dublin, ohio--(business wire)--following the company's fix, fund, propel approach, the proposal substantially undervalues navidea and is not in the best interests of stockholders.

NAVB Ratings Summary

NAVB Quant Ranking